Best EGFR, ALK, ROS1, PG-L1 Doctors Worldwide — TOP 14

Dr. Mustafa Solak completed specialized oncology training at the MD Anderson Cancer Center. His work focuses on lung and breast cancer diagnostics, including EGFR, ALK, ROS1, and PD-L1 testing.

• Fellowship-trained at the Hacettepe University Cancer Institute – a top Turkish oncology center
• Expertise in targeted therapy and immunotherapy using advanced biological markers
• Administers systemic treatments for complex lung and gastrointestinal malignancies
• Member of the oncology team at Hisar Hospital – a JCI-accredited facility

Professor Ofer Merimsky directs the bone and soft tissue sarcoma center at Sourasky Medical Center. He serves as the oncology institute deputy director and leads the lung cancer service.

• Specializes in thoracic cancers requiring EGFR, ALK, ROS1, and PG-L1 biomarker testing
• Trained in thoracic oncology at New York Hospital in the USA
• Provides targeted therapy and immunotherapy based on specific genetic tumor markers
• Former Chairman of the Department of Oncology at Tel Aviv University
• Expert member of the International Association for the Study of Lung Cancer

Professor Tahsin Ozatli is an oncology specialist at Istinye University Liv Hospital Bahcesehir. He focuses on the genetic testing of tumors like EGFR, ALK, and ROS1.

• Promoted to Associate Professor for his work in clinical oncology
• Trained at the Ankara Oncology Clinic, a major center for cancer research
• Expert in lung cancer diagnostics and choosing targeted therapies
• Practiced as a physician at the Erzurum Regional Training and Research Hospital

Dr. Elnur Sahibov specializes in radiation oncology at Emsey Hospital. He provides targeted care through genetic marker testing including EGFR, ALK, ROS1, and PD-L1.

• Completed specialization training in radiation oncology at Marmara University
• Focuses on precision medicine mapping for advanced tumor diagnostics
• Experienced in English-language medical protocols from Marmara University
• Practices at Emsey Hospital, a major multidisciplinary medical center

Dr. Raj Nagarkar has performed 50,000 surgeries and leads HCG Manavata Cancer Centre. He specializes in thoracic oncology, focusing on lung and esophageal cancers.

• Performed over 50,000 cancer surgeries during his career
• Uses EGFR, ALK, and ROS1 testing for personalized lung cancer care
• Participated in 200 clinical trials for new cancer treatments
• Fellow of the Royal College of Surgeons of Edinburgh
• Trained at Tata Memorial Hospital – India's top cancer center

Dr. Shaunak Valame specializes in molecular oncology at HCG Manavata Cancer Centre. He identifies specific cancer mechanisms to guide EGFR, ALK, ROS1, and PG-L1 marker testing.

• Earned a DNB in Medical Oncology from the prestigious Indraprastha Apollo Hospital
• Presented stomach cancer research to the American Society of Clinical Oncology in San Francisco
• Member of ASCO, the leading global body for cancer treatment and research standards
• Former lecturer at AIIMS Bhopal – one of India premier medical education institutes
• Focuses on targeted therapies that attack cancer cells while sparing healthy tissue

Dr. Ahmer Arif Shaikh is a fellow-trained head and neck surgical oncologist at HCG Manavata Cancer Centre. He focuses on organ preservation techniques while treating complex oral and facial cancers.

• Performed fellowships at HCG Manavata Cancer Centre – a top NABH-accredited oncology facility
• Specializes in early diagnosis of oral cancers including EGFR and ALK related cases
• Performs reconstruction surgery to help patients recover functional use of their jaw and mouth
• Published research in major national and international medical journals
• Member of the surgical oncology team treating thyroid and tongue cancers

Dr. Shruti Kate leads medical oncology at HCG Manavata Cancer Centre. She specializes in targeted lung cancer testing and advanced immunotherapy treatments.

• Solo recipient of the travel award from India at the 2018 World Conference on Lung Cancer
• Former consultant at Tata Memorial Hospital – India's premier cancer treatment and research institution
• Expert in identifying biomarkers like EGFR, ALK, and ROS1 for precise lung cancer treatment
• Active member of the International Association for the Study of Lung Cancer (IASLC)
• Board-certified medical oncologist with a DM degree from Tata Memorial Hospital

Dr. Chaitainya Borde has handled over 30,000 PET scans at HCG Manavata Cancer Centre. These imaging skills support precise biomarker testing for EGFR, ALK, and ROS1 mutations.

• Expert in nuclear scanning and PET-CT imaging for cancer staging
• Provides radioiodine and Lu-177 therapies for targeted cancer treatment
• Managed care for over 1,000 thyroid cancer patients
• Published research papers in several respected medical journals
• Specializes in nuclear cardiology services for heart health assessment

Dr. Sridhar P.S. is a specialist in radiotherapy who performs advanced tumor analysis, including EGFR, ALK, ROS1, and PD-L1 testing.

• Holds a Doctor of Medicine in radiotherapy from Banaras Hindu University
• Diplomate of the National Board in radiotherapy since 2004
• Member of the Society for Neuro-Oncology for brain tumor expertise
• Active in the Association of Radiation Oncology of India
• Specializes in using targeted diagnostics to plan precise cancer treatments

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages tumor diagnostics like EGFR, ALK, ROS1, and PD-L1 testing for lung cancer patients.

• Completed a post-doctoral radiation fellowship at Thomas Jefferson University in the USA
• Conducted oncology research at the National Cancer Institute in Bethesda
• Experienced using CyberKnife – a robotic system for precision radiation treatment
• Former Coordinator of Oncological Sciences at Anadolu Medical Center
• Served as Chairman of Radiation Oncology at Uludağ University Medical College

Dr. Cubillo Gracián pioneered the liquid biopsy program in Spain. He uses molecular markers like EGFR, ALK, and ROS1 to create personalized cancer treatment plans.

• Head of Medical Oncology at Hospital Universitario HM Sanchinarro
• Director of Postgraduate Research at HM CIOCC USP CEU
• Co-investigator for the Start Madrid clinical trials program
• Specializes in molecular tumor analysis through advanced blood-based testing
• Associate Professor of Oncology at USP CEU university